Related Experiment Videos

Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease

D R Gaya, J F Mackenzie

QJM : Monthly Journal of the Association of Physicians

|September 3, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.

Journal of Crohn's & colitis·2019

Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?

Frontline gastroenterology·2017

Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.

Alimentary pharmacology & therapeutics·2016

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.

Alimentary pharmacology & therapeutics·2014

Muscle activity during lifting: examining the effect of core conditioning of multifidus and transversus abdominis.

Work (Reading, Mass.)·2013

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

Alimentary pharmacology & therapeutics·2013

See all related articles